Qnexa Tagged Articles

New indications for Topamax mean more unborn babies may be exposed to side effects

Posted: January 6, 2013 Pharmaceutical

The anti-epilepsy drug Topamax (topriamate) is being used for more conditions than to prevent seizures in epileptics. The Food and Drug Administration (FDA) has approved the Topamax for the treatment of migraine headaches in adults, and most recently for weight

FDA approves Belviq, first weight loss drug in more than a decade

Posted: June 29, 2012 Pharmaceutical

A new prescription weight-loss pill has been approved by the Food and Drug Administration (FDA), making it the first diet pill to hit the U.S. market in more than a decade. Arena Pharmaceuticals Belviq (lorcasserin) was deemed safe enough to

FDA approves new medication for erectile dysfunction

Posted: May 4, 2012 Pharmaceutical

Move over Viagra and Cialis, there’s a new erectile dysfunction drug in town, and it’s name is Stendra.

Dr. Oz show investigates risks, benefits of new diet drug

Posted: May 4, 2012 Pharmaceutical

An investigational diet drug is getting media attention from celebrity doctor Dr. Oz as the “New Silver Bullet for Weight Loss,” but the Food and Drug Administration (FDA) has yet to approve the drug based on health concerns including heart

FDA delays vote on experimental diet drug Qnexa

Posted: April 11, 2012 Pharmaceutical

Approval for the experimental weight loss drug Qnexa has been pushed back another three months, paving the way for other drugs to stretch ahead in the race for the first diet pill in 13 years to be granted marketing rights

FDA advises diet drug makers to assess heart risks

Posted: April 3, 2012 Product Liability

Pharmaceutical companies who develop weight loss drugs need to study their medications to determine heart risks before seeking approval from health regulators, the Food and Drug Administration (FDA) said in a report released this week.

Experimental diet drug shows promise for those with type 2 diabetes

Posted: February 27, 2012 Pharmaceutical

An experimental diet pill is one step closer to becoming available for people who are obese or overweight with conditions such as hypertension and type 2 diabetes. A Food and Drug Administration (FDA) advisory panel recommended the approval of Qnexa

FDA panel recommends approval of controversial diet drug Qnexa

Posted: February 23, 2012 Pharmaceutical

A new diet drug may soon be available for people battling the bulge, but it may come at a price. This week, a Food and Drug Administration (FDA) advisory panel reviewed clinical data on the weight loss drug Qnexa and

FDA considers approval of diet drug despite birth defects, heart risks

Posted: February 23, 2012 Pharmaceutical

Drug maker Vivus Inc., is hoping to win Food and Drug Administration (FDA) approval for its diet drug Qnexa this week after a rejection in 2010 due to serious health concerns. Experts say the chances of the weight loss drug

FDA to consider diet pill with birth defects warning

Posted: October 19, 2011 Product Liability

California-based drug company Vivus Inc. is hoping to win Food and Drug Administration (FDA) approval for its experimental diet drug Qnexa, after it was rejected last October because of concerns that it may cause birth defects and increased heart rate.